SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 µM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzyme. Oral administration of SARS-CoV
Molecular Weight:
282.12
CAS Number:
[22203-98-1]
Formula:
C13H9Cl2NO2
Target:
SARS-CoV
T60538
* VAT and and shipping costs not included. Errors and price changes excepted